drugset / Trial / NCT04092595
A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
A phase 1, 2-period, fixed-sequence, multiple-dose, open-label study of the effect of PF-06651600 on Rosuvastatin pharmacokinetics in healthy participants. Approximately 12 healthy male and/or female participants will be enrolled in the study.
Timeline
- Start
- 2019-09-26
- Primary completion
- 2020-01-15
- Completion
- 2020-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritlecitinib | Small molecule | 200 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 10 mg | Oral |
Indications
No indication recorded.